Novolog (Pharm-Up 1966) Ltd (TLV: NVLG)

Novolog (Pharm-Up 1966) Ratios and Metrics

Market cap in millions ILS. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	778	726	1,409	1,504	1,423	783
Market Cap Growth	-15.83%	-48.50%	-6.30%	5.66%	81.80%	100.06%
Enterprise Value	765	674	1,470	1,449	1,385	664
Last Close Price	1.52	1.37	2.62	2.75	2.78	1.52
PE Ratio	-	-16.60	28.51	33.53	32.73	58.32
PS Ratio	0.46	0.44	0.93	1.20	1.26	0.78
PB Ratio	2.05	1.83	3.03	3.50	4.81	2.97
P/FCF Ratio	-62.75	5.62	22.31	28.51	43.30	10.24
P/OCF Ratio	15.87	3.63	10.62	18.03	24.33	7.72
EV/Sales Ratio	0.45	0.41	0.98	1.15	1.22	0.66
EV/EBITDA Ratio	5.23	5.42	15.60	15.81	17.28	10.80
EV/EBIT Ratio	15.28	12.50	18.90	20.87	24.07	16.56
EV/FCF Ratio	-62.31	5.23	23.28	27.46	42.13	8.68
Debt / Equity Ratio	0.52	0.54	0.46	0.39	0.52	0.60
Debt / EBITDA Ratio	1.37	1.46	1.86	1.55	1.62	2.04
Debt / FCF Ratio	-16.84	1.67	3.37	3.16	4.69	2.07
Asset Turnover	0.59	0.63	0.64	0.56	0.52	0.52
Inventory Turnover	6.53	6.74	7.07	4.98	4.26	4.56
Quick Ratio	0.86	0.84	0.87	0.91	0.84	0.85
Current Ratio	0.96	0.96	0.98	1.03	0.99	0.98
Return on Equity (ROE)	-3.65%	-9.15%	11.38%	12.35%	14.50%	5.48%
Return on Assets (ROA)	1.20%	1.29%	2.06%	1.94%	1.66%	1.29%
Return on Capital (ROIC)	5.43%	5.24%	7.63%	8.29%	8.25%	9.47%
Earnings Yield	-2.30%	-5.79%	3.37%	2.81%	2.82%	1.29%
FCF Yield	-1.58%	17.78%	4.48%	3.51%	2.31%	9.76%
Dividend Yield	3.86%	2.15%	2.50%	3.41%	0.93%	2.84%
Payout Ratio	0.00%	-	67.14%	75.62%	29.95%	152.86%
Buyback Yield / Dilution	0.61%	0.94%	-0.14%	-9.08%	-22.06%	-10.54%
Total Shareholder Return	4.46%	3.10%	2.36%	-5.67%	-21.12%	-7.70%

Source: S&P Capital IQ. Standard template. Financial Sources.